Prescribing trends for combination products in the treatment of type-II diabetes

被引：0
|
作者：
Bilek, JC
Carlson, A
Morris, LS
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Data Intelligence, Eden Prairie, MN USA
[3] IMS Hlth, Plymouth Meeting, PA USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62966-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [21] Type-II diabetes mellitus - Pathogenesis and rational treatment
    Matthaei, S
    [J]. MEDIZINISCHE WELT, 1995, 46 (12): : 564 - 571
  • [22] Natural Products for Type II Diabetes Treatment
    Bedekar, Amruta
    Shah, Karan
    Koffas, Mattheos
    [J]. ADVANCES IN APPLIED MICROBIOLOGY, VOL 71, 2010, 71 : 21 - 73
  • [23] HYPERPROINSULINEMIA IN TYPE-II DIABETES
    COHEN, RM
    NATHAN, DM
    CLEMENTS, RS
    [J]. DIABETES CARE, 1992, 15 (05) : 723 - 724
  • [24] NEPHROPATHY IN TYPE-II DIABETES
    RITZ, E
    STEFANSKI, A
    LIPPERT, J
    [J]. JOURNAL OF NEPHROLOGY, 1995, 8 (03) : 128 - 132
  • [25] HETEROGENEITY IN TYPE-II DIABETES
    CAHILL, GF
    [J]. WESTERN JOURNAL OF MEDICINE, 1985, 142 (02): : 249 - 250
  • [26] HLA TYPE-II AND DIABETES
    BACH, JF
    [J]. M S-MEDECINE SCIENCES, 1991, 7 (03): : 287 - 287
  • [27] FENFLURAMINE FOR TYPE-II DIABETES
    HEPP, KD
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (19) : 769 - 769
  • [28] OSTEOPOROSIS IN TYPE-II DIABETES
    ISAIA, G
    BODRATO, L
    CARLEVATTO, V
    MUSSETTA, M
    SALAMANO, G
    MOLINATTI, GM
    [J]. ACTA DIABETOLOGICA LATINA, 1987, 24 (04): : 305 - 310
  • [29] DIET IN TYPE-II DIABETES
    RABAST, U
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1982, 124 (49): : 1113 - 1116
  • [30] THE NEGLECTED DIABETES TYPE-II
    MEHNERT, H
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1988, 130 (06): : 59 - 60
12345